Use of Oxygen in Heart Failure With Preserved Ejection Fraction
STOP-EF
Randomised, Cross Over, Single Blind, Control Trial of Short Term Oxygen Use During Cycle Ergometry in Patients With Chronic Heart Failure With Preserved Ejection Fraction
1 other identifier
interventional
50
0 countries
N/A
Brief Summary
Oxygen is routinely given to patients with common conditions such as COPD and heart failure. There is no evidence behind giving oxygen to patients specifically in heart failure due to a stiff heart. This study aims to explore the effect oxygen has on the ability of patients with chronic heart failure and the ability to exercise. Other common variables will be assessed such as heart rate and blood pressure to observe the response to varying concentrations of oxygen. The concentrations chosen are commonly offered in hospitals and indeed are being delivered through standard equipment found in all hospitals in the country. It is hoped that studying the effect of short term oxygen on patients with heart failure will help to identify the effectiveness of oxygen in longer term therapy for patients who are often breathless with a decreased exercise tolerance.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_2 heart-failure
Started Nov 2016
Shorter than P25 for phase_2 heart-failure
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 3, 2016
CompletedFirst Posted
Study publicly available on registry
October 31, 2016
CompletedStudy Start
First participant enrolled
November 3, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 15, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
February 15, 2017
CompletedJune 26, 2019
September 1, 2016
3 months
October 3, 2016
June 24, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
change in exercise time with the use of 21%, 28% and 40% oxygen
the total time cycled in each arm
at 3 weeks
Secondary Outcomes (2)
change in shortness of breath with the use of 21%, 28% and 40% oxygen
at 3 weeks
change in Peak metabolic equivalent with the use of 21%, 28% and 40% oxygen
at 3 weeks
Study Arms (3)
21% oxygen
ACTIVE COMPARATORroom air will be delivered via Venturi mask during cycle ergometry
28% oxygen
ACTIVE COMPARATOR28% oxygen will be delivered via Venturi mask during cycle ergometry
40% oxygen
ACTIVE COMPARATOR40% oxygen will be delivered via Venturi mask during cycle ergometry
Interventions
Eligibility Criteria
You may qualify if:
- Over 50 years of age and able and willing to give consent
- Have signs and/or symptoms of heart failure
- Left ventricular ejection fraction \> 45%
- NT-pro BNP \> 220 pg/ml (in the previous 12 months)
- On any diuretic
You may not qualify if:
- Unable or unwilling to give consent
- Recent (\<1 month) acute myocardial infarct or cerebrovascular event
- Significant renal dysfunction (eGFR \<30 ml.min-1.1.73m-2)
- Significant anaemia (Haemoglobin \< 100 g.L-1)
- Systolic blood pressure \<90 mmHg, or \>180 mmHg
- Severe mitral or aortic valve disease
- Diagnosis of severe chronic lung disease
- Involvement in another medicinal trial within the past four weeks
- Unable to use cycle
- Any planned admission in the following 3-4 weeks (patient can be reconsidered for enrolment after planned admission)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Shah P, Pellicori P, Rimmer S, Rigby AS, Clark AL. Effect of increased inspired oxygen on exercise performance in patients with heart failure and normal ejection fraction. Int J Cardiol. 2018 Oct 1;268:166-169. doi: 10.1016/j.ijcard.2018.05.029. Epub 2018 May 24.
PMID: 29803343BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Andrew Clark
Castle Hill Hospital
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 3, 2016
First Posted
October 31, 2016
Study Start
November 3, 2016
Primary Completion
February 15, 2017
Study Completion
February 15, 2017
Last Updated
June 26, 2019
Record last verified: 2016-09
Data Sharing
- IPD Sharing
- Will not share